本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

7.12
+0.22003.19%
成交量:57.88万
成交额:410.21万
市值:6.88亿
市盈率:-15.15
高:7.24
开:7.00
低:6.78
收:6.90
数据加载中...
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/29

重要事件披露

Form 8-K - Current report
2023/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report
2023/04/11

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals